Banner Image

Test Directory

CBFB/MYH11 inv(16), Quantitative, Real-Time PCR

Order Code: CBFBMY

Test Summary

This Real-Time Quantitative (Reverse Transcription Polymerase Chain Reaction) for the amplification of CBFB/MYH11 fusion transcript can be used to detect the chromosome aberration of inv (16) or t (16;16). It can be used to detect Minimal Residual Disease (MRD) and assess the risk for disease relapse in inv (16) or t (16;16) Acute Myeloid Leukemia (AML).

Aliases

  • N/A

Specimen Collection

Order Code

CBFBMY

EPIC (Premier) Code

LAB6317

Includes

N/A

CPT Code

  • 81401

Billing Code

  • 670633

CPT Statement

Methodology

Real-Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
33608 Ortega Highway
San Juan Capistrano CA, 92675

Department

Reference Testing

Reference Range

Negative

Setup Schedule / Expected Turnaround Time

Tuesday; Report available: 6 days

Specimen Collection

Billing

CPT Code

  • 81401

Billing Code

  • 670633

CPT Statement

Result Information

Methodology

Real-Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)

Testing Laboratory

N/A

Reference Range

Negative

Setup Schedule / Expected Turnaround Time

Tuesday; Report available: 6 days